Rosti Group’s Malaysia Molding Site Achieves ISO13485 Certification
The London headquartered plastic injection molding company said the certification of the Malaysian site will allow medical device manufacture there.
Rosti Group announced that its Malaysia injection molding facility has achieved ISO13485 certification, clearing the way for medical device manufacturing at the site. The 5000-m² (approx. 54,000-ft2) facility is Rosti’s fourth plant to attain ISO13485, following China, Romania and Poland.
In addition to injection molding, printing, assembly, process development, tooling and supply chain management, the Malaysia has expertise in the production and validation of complex products. Rosti notes that it was involved in the development and production of a 15-minute COVID-19 saliva test.
Based in Johor, Rosti Malaysia employs 90 staff. Rosti operates eight facilities worldwide, including two Digital Innovation Labs with a third being added in the U.S. Rosti is planning a future investment into a controlled manufacturing area with medical specified injection molding machines.
Located in Johor, Rosti’s Malaysian injection molding facility has achieved ISO13485 certification.
Photo Credit: Rosti Group
Related Content
-
Allegheny Performance Plastics to Enter Health Care Sector
The custom molder has secured multiple projects in health care and will be adding cleanroom and white-room spaces, as well as injection molding machines, in support.
-
DuPont Buys Medical Product Manufacturer Spectrum Plastics
Purchase price of $1.75 billion for leading supplier of extruded, molded, and 3D printed medical components.
-
Consistent Shots for Consistent Shots
An integral supplier in the effort to fast-track COVID-19 vaccine deployment, Retractable Technologies turned to Arburg and its PressurePilot technology to help deliver more than 500 million syringes during the pandemic.
